Aethlon Medical, Inc. (AEMD)
$5.58-4.78%Close
BUYCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 1.40
- P/E (TTM)
- -0.48
- Shares short
- 75.4K
- Days to cover
- 1.0
- SI change
- +0.8%
- 1W
- -8.37%
- 1M
- +262.34%
- vs SPY 1W
- -8.24%
- vs SPY 1M
- +259.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 18
- GROWTH
- 51
- GARP
- 5
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-73.9%
REV YoY-
ROE-38.6%
EPS YoY-
ROA-111.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.48
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B0.41
P/FCF-
EV/EBITDA0.25
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E7.07
ALTMAN Z-
CURR RATIO5.42
ND/EBITDA-
BETA1.40
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on AEMD?
- LOPJLB’s latest quantitative signal on Aethlon Medical, Inc. (AEMD) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is AEMD in?
- Aethlon Medical, Inc. (AEMD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aethlon Medical, Inc. (AEMD) do?
- Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-deriv…